It’s All Connected
If the scientific community wants to tackle neurological disorders, it needs to shift its focus beyond the brain – the gut also plays a role.
Maryam Mahdi | | Longer Read
Do neurological disorders begin in the brain or elsewhere? Mounting research now points to the enteric nervous system (ENS) – our second brain – in the onset of central nervous system (CNS) disorders like Parkinson’s Disease (PD). The ENS has an extensive connection to the brain and is integral to gastrointestinal function. Some biotech companies, such as Axial Biotherapeutics, are beginning to explore the gut-brain axis for the development of novel therapeutics for diseases and disorders affecting the CNS. Axial was founded in 2016 to pursue non-traditional approaches to treating CNS diseases by targeting the gut rather than the blood-brain barrier to treat disease.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.